MR spectroscopy, APOE genotype, and evolving β-amyloid pathology: What is being detected and when

Affiliations

¹ From the Department of Radiology (K.K.), Division of Neuroradiology, Mayo Clinic, Rochester, MN; and the Department of Psychiatry and Molecular Medicine (T.E.G.), Hofstra Northwell School of Medicine, Hempstead, NY. kantarci.kejal@mayo.edu.
² From the Department of Radiology (K.K.), Division of Neuroradiology, Mayo Clinic, Rochester, MN; and the Department of Psychiatry and Molecular Medicine (T.E.G.), Hofstra Northwell School of Medicine, Hempstead, NY.

Editorial

Kejal Kantarci et al. Neurology. 2016.

. 2016 May 10;86(19):1750-1.

doi: 10.1212/WNL.0000000000002680. Epub 2016 Apr 15.

¹ From the Department of Radiology (K.K.), Division of Neuroradiology, Mayo Clinic, Rochester, MN; and the Department of Psychiatry and Molecular Medicine (T.E.G.), Hofstra Northwell School of Medicine, Hempstead, NY. kantarci.kejal@mayo.edu.
² From the Department of Radiology (K.K.), Division of Neuroradiology, Mayo Clinic, Rochester, MN; and the Department of Psychiatry and Molecular Medicine (T.E.G.), Hofstra Northwell School of Medicine, Hempstead, NY.

No abstract available

Comment on

Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.
Voevodskaya O, Sundgren PC, Strandberg O, Zetterberg H, Minthon L, Blennow K, Wahlund LO, Westman E, Hansson O; Swedish BioFINDER study group. Voevodskaya O, et al. Neurology. 2016 May 10;86(19):1754-61. doi: 10.1212/WNL.0000000000002672. Epub 2016 Apr 15. Neurology. 2016. PMID: 27164711 Free PMC article.